🇺🇸 FDA
Patent

US 9540643

Organic compositions to treat HSF1-related diseases

granted A61KA61K31/713A61K45/06

Quick answer

US patent 9540643 (Organic compositions to treat HSF1-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P19/02